ALS News & Research For postings of news or research links and articles related to ALS


advertisement
Reply
 
Thread Tools Display Modes
Old 03-26-2017, 04:00 PM #1
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
 
Join Date: Feb 2007
Posts: 3,269
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,269
15 yr Member
Default . . . this appears to be an advertisment . . .

Treatment Options for Amyotrophic Lateral Sclerosis (ALS/Lou Gehrigs Disease) – MilTech


really good at making it look like a news item , , ,

NOTICE THE STRANGE ERROR . . .

" . . . If there are 25,000 to 50,000 newly diagnosed patients in the US, why are there only a few FDA approved drugs? Rizole (Rilutek) is the . . . "

***WARNING***
MuonOne is offline   Reply With QuoteReply With Quote

advertisement
Reply

Tags
000, diagnosed, newly, patients, advertisment


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
It IS back :( and appears to be spreading jennq78 Reflex Sympathetic Dystrophy (RSD and CRPS) 4 05-24-2013 06:00 PM
Chronic Progressive Illness Not Always as It Appears NeuroNixed Craig Multiple Sclerosis 11 10-29-2011 05:56 AM
Abilities Expo appears to be doing it right BobbyB ALS 0 09-02-2007 09:09 PM


All times are GMT -5. The time now is 11:42 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.